Abstract:SESSION TITLE: Diffuse Lung Disease Posters 5 SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/11/2023 12:00 pm - 12:45 pm PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a highly fatal lung disease of unknown cause with a median survival time of only 3-5 years. Current evidence manifests differentiation of lung fibroblasts into αSMA-positive myofibroblasts is important in the progress of IPF. However, few biomarkers reflecting the fibrotic process have been identified. In this study, we aim to explore whether LTBP2 is a new potential biomarker for predicting the progression and diagnosis of IPF, and which cell population may be the main cells for LTBP2 highly expressed to promote the progression of IPF disease. METHODS: The microarray data of GSE17978 and GSE53845 datasets were downloaded from the GEO database to analyze differentially expressed genes. Single-cell transcriptomic data of IPF patients and healthy donors were selected from GSE122960. IPF and healthy donor lung tissue samples were acquired from the First Affiliated Hospital of Zhengzhou University. This study was approved by Ethical Committee for Scientific Research and Clinical Trials of the First Affiliated Hospital of Zhengzhou University. The isolated lung tissue was placed in 10% formalin within half an hour and subsequently embedded in paraffin. Paraffin sections were used for HE and Masson staining to find fibroblast foci. Immunohistochemical techniques were used to detect the expression of LTBP2 in fibroblasts/myofibroblasts in the fibroblast foci of IPF lung tissues. Starving MRC-5 cells and CCC-HPF-1 cells in DMEM medium without fetal bovine serum for 12 hours, respectively, and then adding TGF-β1 at a concentration of 10 ng/ml. After 48 hours of stimulation, a fibrotic phenotype of fibroblasts was constructed. RESULTS: Utilizing GSE17978 and GSE53845 data, we found that the mRNA level of LTBP2 in IPF lung tissue was significantly higher than that in healthy lung tissue. In GSE122920 data, 14 major cell populations were clustered and identified based on screening out the expression of canonical cell markers. LTBP2 was strongly expressed in the fibroblast population. Additionally, LTBP2 was highly expressed in fibroblasts from IPF while fibroblasts from healthy donors rarely expressed LTBP2. Next, immunohistochemical analysis showed that LTBP2 was extensively positive in IPF lung tissue, and LTBP2 was strongly positive in fibroblasts/myofibroblasts in the fibroblast foci. Using serum-free DMEM containing 10 ng/ml of TGF-β1 to culture MRC-5 and CCC-HPF-1 cells respectively, the mRNA level of LTBP2 increased in a time-dependent manner, reaching the peak at 48 hours. CONCLUSIONS: In conclusion, we developed a validated and reproducible IRG-based prognostic signature that should be helpful for the personalized management of patients with IPF. CLINICAL IMPLICATIONS: Providing a new direction for targeted treatment of IPF. DISCLOSURES: No relevant relationships by Shanshan Chen No relevant relationships by Zemin Fang No relevant relationships by Liang Guo No relevant relationships by Chun Huang No relevant relationships by Hongxia Jia No relevant relationships by Hui Li No relevant relationships by Chunya Lu No relevant relationships by Lingxiao Qiu No relevant relationships by Wenjuan Wu No relevant relationships by Zhi Xu No relevant relationships by Xinye Zhang No relevant relationships by Guojun Zhang No relevant relationships by Huasi Zhao

Interaction of osteoprotegerin with fibulin-1 is essential for extracellular matrix deposition in fibrotic lung tissue

Osteoprotegerin is elevated in pulmonary fibrosis and associates with IPF progression

Abnormal expression of IGF-binding proteins, an initiating event in idiopathic pulmonary fibrosis?

Suppression of OGN in lung myofibroblasts attenuates pulmonary fibrosis by inhibiting integrin αv-mediated TGF-β/Smad pathway activation

Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts

Osteoprotegerin is an Early Marker of the Fibrotic Process and of Antifibrotic Treatment Responses in Ex Vivo Lung Fibrosis

O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis

Gremlin2 Activates Fibroblasts to Promote Pulmonary Fibrosis Through the Bone Morphogenic Protein Pathway

The Role Of Fibulin-1C Peptides In Attachment, Proliferation And ECM Deposition In Lung Fibroblasts From Chronic Lung Diseases

Mannan-Binding Lectin Reduces Epithelial-Mesenchymal Transition in Pulmonary Fibrosis Via Inactivating the Store-Operated Calcium Entry Machinery

Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis

Differential Regulation of Extracellular Matrix and Soluble Fibulin-1 Levels by TGF-β₁ in Airway Smooth Muscle Cells.

Osteoprotegerin expression in liver is induced by IL-13 through TGF-β

Identification of a fibronectin-binding protein signature associated with idiopathic pulmonary fibrosis

Regulation of extracellular matrix gene expression and biosynthetic pathways in pulmonary fibroblasts by HSF1

The Critical Role of Osteopontin (OPN) in Fibrotic Diseases

Ficolin-1 Ameliorates Pulmonary Fibrosis Via Directly Binding to TGF-β1

Interleukin-1α inhibits transforming growth factor-β1 and β2-induced extracellular matrix production, remodeling and signaling in human lung fibroblasts: Master regulator in lung mucosal repair

Fibroblast-derived extracellular vesicles contain SFRP1 and mediate pulmonary fibrosis

Ltbp2 is a potential biomarker reflecting the fibrotic progression

Role of lung ornithine aminotransferase in idiopathic pulmonary fibrosis: regulation of mitochondrial ROS generation and TGF-β1 activity